Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
about
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
@en
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
@nl
type
label
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
@en
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
@nl
prefLabel
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
@en
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma
@en
P2093
Alexandr M Volkov
Alexei L Krivoshapkin
Alexei S Gaitan
Diana V Kostromskaya
Elvira V Grigorieva
Galina M Kazanskaya
Roman S Kiselev
Vyacheslav V Kobozev
P2860
P304
1010428317724282
P356
10.1177/1010428317724282
P577
2017-09-01T00:00:00Z